70 related articles for article (PubMed ID: 12700896)
1. Proliferation and Angiogenesis Using Immunohistochemistry in Prognosticating Multiple Myeloma.
Priyadarshini SG; Basu D; Kar R; Dutta TK
Indian J Hematol Blood Transfus; 2016 Dec; 32(4):418-423. PubMed ID: 27812250
[TBL] [Abstract][Full Text] [Related]
2. The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients.
Lemancewicz D; Bolkun L; Jablonska E; Czeczuga-Semeniuk E; Kostur A; Kloczko J; Dzieciol J
Med Sci Monit; 2012 Jan; 18(1):BR54-59. PubMed ID: 22207110
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological underpinnings of multiple myeloma progression.
Jagannath S
J Manag Care Pharm; 2008 Sep; 14(7 Suppl):7-11. PubMed ID: 18774880
[TBL] [Abstract][Full Text] [Related]
4. Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma.
Carlisi M; Presti RL; Plano F; Mancuso S; Siragusa S; Caimi G
Sci Rep; 2024 Feb; 14(1):2832. PubMed ID: 38310176
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.
Nabissi M; Morelli MB; Offidani M; Amantini C; Gentili S; Soriani A; Cardinali C; Leoni P; Santoni G
Oncotarget; 2016 Nov; 7(47):77543-77557. PubMed ID: 27769052
[TBL] [Abstract][Full Text] [Related]
6. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
[TBL] [Abstract][Full Text] [Related]
7. Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent.
Jia D; Koonce NA; Halakatti R; Li X; Yaccoby S; Swain FL; Suva LJ; Hennings L; Berridge MS; Apana SM; Mayo K; Corry PM; Griffin RJ
Radiat Res; 2010 Jun; 173(6):809-17. PubMed ID: 20518660
[TBL] [Abstract][Full Text] [Related]
8. Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity.
Tian Y; Ding RY; Zhi YH; Guo RX; Wu SD
World J Gastroenterol; 2006 Jan; 12(3):415-9. PubMed ID: 16489641
[TBL] [Abstract][Full Text] [Related]
9. Bcl-xl expression in multiple myeloma.
Peeters SD; Hovenga S; Rosati S; Vellenga E
Med Oncol; 2005; 22(2):183-90. PubMed ID: 15965282
[TBL] [Abstract][Full Text] [Related]
10. Expression of receptor activator of NF-kappaB ligand (RANKL) mRNA in human multiple myeloma cells.
Heider U; Zavrski I; Jakob C; Bängeroth K; Fleissner C; Langelotz C; Possinger K; Hofbauer LC; Viereck V; Sezer O
J Cancer Res Clin Oncol; 2004 Aug; 130(8):469-74. PubMed ID: 15205949
[TBL] [Abstract][Full Text] [Related]
11. Correlation of P-glycoprotein expression with poor vascularization in human gallbladder carcinomas.
Tian Y; Zhu LL; Guo RX; Fan CF
World J Gastroenterol; 2003 Dec; 9(12):2817-20. PubMed ID: 14669341
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion.
Zavrski I; Naujokat C; Niemöller K; Jakob C; Heider U; Langelotz C; Fleissner C; Eucker J; Possinger K; Sezer O
J Cancer Res Clin Oncol; 2003 Jul; 129(7):383-91. PubMed ID: 12851815
[TBL] [Abstract][Full Text] [Related]
13. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.
Himani B; Meera S; Abhimanyu S; Usha R
Asian Pac J Cancer Prev; 2016; 17(5):2559-64. PubMed ID: 27268630
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies.
De Raeve H; Van Marck E; Van Camp B; Vanderkerken K
Histol Histopathol; 2004 Jul; 19(3):935-50. PubMed ID: 15168356
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in multiple myeloma.
Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
